- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Dongkook Pharmaceutical Co Ltd (086450)
Dongkook Pharmaceutical Co Ltd stock price live, this page displays KQ 086450 stock exchange data. View the 086450 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Dongkook Pharmaceutical Co Ltd real time stock price chart below.
What Is the Dongkook Pharmaceutical Co Ltd Stock Price Today?
The Dongkook Pharmaceutical Co Ltd stock price today is 17,250.
What Is the Stock Symbol for Dongkook Pharmaceutical Co Ltd?
The stock symbol for Dongkook Pharmaceutical Co Ltd is "086450."
What Stock Exchange Does Dongkook Pharmaceutical Co Ltd Trade On?
Dongkook Pharmaceutical Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is Dongkook Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Dongkook Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 086450 quote. (ISIN: KR7086450004)
What Is the Dongkook Pharmaceutical Co Ltd Stock Price Today?
The Dongkook Pharmaceutical Co Ltd stock price today is 17,250.
What Is the Stock Symbol for Dongkook Pharmaceutical Co Ltd?
The stock symbol for Dongkook Pharmaceutical Co Ltd is "086450."
What Stock Exchange Does Dongkook Pharmaceutical Co Ltd Trade On?
Dongkook Pharmaceutical Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is Dongkook Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Dongkook Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 086450 quote. (ISIN: KR7086450004)
KOSDAQ
Currency in KRW
17,250
+610(+3.67%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16,820
17,390
52 wk Range
14,400
20,600
086450 Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
086450 is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16,82017,390
52 wk Range
14,40020,600
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.20%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.20%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
086450 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
23,000
Upside
+33.33%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
No news in this category
Looks like there are no results in this news category
Dongkook Pharmaceutical Company Profile
DongKook Pharmaceutical Co., Ltd. produces and sell pharmaceutical products in South Korea and internationally. The company offers non-prescription and prescription drugs, quasi drugs, medical devices, active pharmaceutical ingredients, and cosmetics. Its pipeline includes DKF-310, which is in preclinical trials for the treatment of dementia; DKM-413, used for anesthetic; DKF-361, used to treat hypertension; DKF-325, an anticoagulant; DKM-412 and DKM-420 to treat osteoarthritis; DKF-313, that is in clinical studies, indicated for benign prostatic hyperplasia; DKF-340, a nonsteroidal anti-inflammatory drugs; DKM-415, indicated for synovial fluid replacement; DKF-334 and DKF-335 to treat osteoporosis; and DKF-363, for treatment of respiratory inflammation. In addition, the company develops DKB-119 and DKM-410, a biomaterial for tissue restoration; as well as develops new drugs for obesity and diabetes that is in preclinical studies. The company was formerly known as UEC & Co., Ltd. and changed its name to DongKook Pharmaceutical Co., Ltd. in March 1982. The company was founded in 1968 and is headquartered in Seoul, South Korea.
Compare 086450 to Peers and Sector
Metrics to compare | 086450 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship086450PeersSector | |
|---|---|---|---|---|
P/E Ratio | 12.6x | 8.1x | −0.5x | |
PEG Ratio | 0.41 | 0.02 | 0.00 | |
Price/Book | 1.3x | 0.9x | 2.6x | |
Price / LTM Sales | 0.9x | 0.7x | 3.0x | |
Upside (Analyst Target) | 38.2% | 58.8% | 54.7% | |
Fair Value Upside | Unlock | 16.0% | 8.4% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 23,000
(+33.33% Upside)
Earnings
Latest Release
May 19, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / 214.10B
FAQ
What Is the Dongkook Pharmaceutical (086450) Stock Price Today?
The Dongkook Pharmaceutical stock price today is 17,250.00.
What Stock Exchange Does Dongkook Pharmaceutical Trade On?
Dongkook Pharmaceutical is listed and trades on the KOSDAQ stock exchange.
What Is the Stock Symbol for Dongkook Pharmaceutical?
The stock symbol for Dongkook Pharmaceutical is "086450."
Does Dongkook Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?
The Dongkook Pharmaceutical dividend yield is 1.2%.
What Is the Dongkook Pharmaceutical Market Cap?
As of today, Dongkook Pharmaceutical market cap is 738.68B.
What Is Dongkook Pharmaceutical's Earnings Per Share (TTM)?
The Dongkook Pharmaceutical EPS (TTM) is 1,382.16.
When Is the Next Dongkook Pharmaceutical Earnings Date?
Dongkook Pharmaceutical will release its next earnings report on 18 Aug 2025.
From a Technical Analysis Perspective, Is 086450 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.